Project Grant 2434965
Award Date
6/1/25
Completion Date
5/31/26
Dollars Obligated
$305K
Federal Agency
National Science Foundation
Awardee
Sostos Inc. (TW4LF32FLS31)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Morgantown, WV 26505, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
The National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) awarded a $190,794 Project Grant to The Research Foundation for the State University of New York (RF SUNY) on October 1, 2024. The grant supports the development of an artificial intelligence (AI)-powered technology to select optimal treatment options for individual cancer patients, with the goal of prolonging patient life. The project aims to establish connections with innovation networks,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Redpoint Oncology, Inc. aims to develop and validate a novel platform for targeted cancer therapies. The project seeks to create "guided missile-like" cancer treatments that can selectively target and destroy therapy-resistant cancer cells. Key research objectives include designing new payload candidates, testing their anti-cancer efficacy and selectivity,...
This National Science Foundation Project Grant of $255,995 supported Encapsulate Inc. to develop an automated biochip platform for personalized cancer screening under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The award period was from May 15, 2022 to April 30, 2023. The platform will grow patient-derived cancer cells outside the body on biochips to screen them against chemotherapy drugs. This addresses the problem that over 70% of cancer patients undergo ineffective...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Beken Bio, Inc. aims to develop a highly sensitive, minimally invasive laboratory test to detect early-stage ovarian cancer by assaying relevant biomarkers on circulating extracellular vesicles in patient plasma. The project will utilize a novel technology to identify key proteins in extracellular vesicles from various ovarian cancer subtypes and employ a machine...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Vivosphere LLC for $275,000 will support the development of a novel tissue-engineered platform for cancer modeling and drug screening. The project aims to create a more physiologically relevant, high-throughput screening model to improve the translation rate between preclinical and clinical testing of anti-cancer drug candidates. The proposed technology utilizes a 3D hydrogel...
This National Science Foundation Project Grant of $606,649 will support the development of an engineered cyber-physical system combining advanced biological models and artificial intelligence methods to enable precision medicine for cancer treatment. Awarded under the Computer and Information Science and Engineering program, the funding will be used by Brigham and Women's Hospital and its parent organization Partners Healthcare System from October 2022 to September 2025. Specifically, the...
This National Science Foundation (NSF) Computer and Information Science and Engineering Program grant (CFDA 47.070) awarded to Auburn University for $490,039 aims to develop novel technologies to better differentiate among cancer patients and personalize treatment. The project will integrate multi-omics data to compute personalized pathway profiles that can be used for cancer subtyping, patient stratification, and risk prediction. This approach will enhance the ability to distinguish patients...
The National Science Foundation (NSF) awarded a $275,000 SBIR Phase I grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Om Therapeutics Inc. in La Jolla, CA. The goal of this project is to enable the discovery of new medicines at an unprecedented rate by empowering researchers to launch drug discovery programs quickly and cost-effectively. The innovation involves the ability to screen billions of unique small molecules against the entire human proteome in a...